NO176480C - Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler - Google Patents

Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler

Info

Publication number
NO176480C
NO176480C NO884833A NO884833A NO176480C NO 176480 C NO176480 C NO 176480C NO 884833 A NO884833 A NO 884833A NO 884833 A NO884833 A NO 884833A NO 176480 C NO176480 C NO 176480C
Authority
NO
Norway
Prior art keywords
tritio
methyl
tumor agents
analogous process
targeted forms
Prior art date
Application number
NO884833A
Other languages
English (en)
Norwegian (no)
Other versions
NO176480B (no
NO884833L (no
NO884833D0 (no
Inventor
William James Mcgahren
Martin Leon Sassiver
George A Ellestad
Phillip R Hamann
Lois M Hinman
Janis Upeslacis
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of NO884833D0 publication Critical patent/NO884833D0/no
Publication of NO884833L publication Critical patent/NO884833L/no
Publication of NO176480B publication Critical patent/NO176480B/no
Publication of NO176480C publication Critical patent/NO176480C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6807—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug or compound being a sugar, nucleoside, nucleotide, nucleic acid, e.g. RNA antisense
    • A61K47/6809—Antibiotics, e.g. antitumor antibiotics anthracyclins, adriamycin, doxorubicin or daunomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO884833A 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler NO176480C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11494087A 1987-10-30 1987-10-30

Publications (4)

Publication Number Publication Date
NO884833D0 NO884833D0 (no) 1988-10-28
NO884833L NO884833L (no) 1989-05-02
NO176480B NO176480B (no) 1995-01-02
NO176480C true NO176480C (no) 1995-04-12

Family

ID=22358378

Family Applications (2)

Application Number Title Priority Date Filing Date
NO884834A NO173506C (no) 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler
NO884833A NO176480C (no) 1987-10-30 1988-10-28 Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler

Family Applications Before (1)

Application Number Title Priority Date Filing Date
NO884834A NO173506C (no) 1987-10-30 1988-10-28 Fremgangsmaate ved fremtilling av disvovelanaloger av ll-E33288-antitumormidler

Country Status (19)

Country Link
EP (2) EP0313874B1 (de)
JP (2) JP2820256B2 (de)
KR (2) KR970011385B1 (de)
AR (1) AR246083A1 (de)
AT (2) ATE104309T1 (de)
AU (2) AU612714B2 (de)
BR (1) BR1100939A (de)
CA (1) CA1321582C (de)
DE (2) DE3851682T2 (de)
DK (2) DK602488A (de)
ES (2) ES2061586T3 (de)
FI (2) FI91262C (de)
HK (2) HK131897A (de)
IE (2) IE65053B1 (de)
IL (2) IL87947A (de)
NO (2) NO173506C (de)
NZ (2) NZ226727A (de)
PT (2) PT88882B (de)
ZA (2) ZA888123B (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5079233A (en) * 1987-01-30 1992-01-07 American Cyanamid Company N-acyl derivatives of the LL-E33288 antitumor antibiotics, composition and methods for using the same
US5606040A (en) * 1987-10-30 1997-02-25 American Cyanamid Company Antitumor and antibacterial substituted disulfide derivatives prepared from compounds possessing a methyl-trithio group
IL115770A (en) * 1989-04-14 1999-03-12 American Cyanamid Co Substituted disulfides of formula q-sp-ss-w their preparation and use for inhibiting the growth of tumours and for treating bacterial infections
GB9007384D0 (en) * 1990-04-02 1990-05-30 Duncan Ruth Coupling between polymers and other organic molecular entities utilising thiol-specific reactive groups
US5712374A (en) * 1995-06-07 1998-01-27 American Cyanamid Company Method for the preparation of substantiallly monomeric calicheamicin derivative/carrier conjugates
US5714586A (en) * 1995-06-07 1998-02-03 American Cyanamid Company Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
NZ512122A (en) 1998-11-27 2003-12-19 Darwin Discovery Ltd Compositions and methods for increasing bone mineralization
US20040009535A1 (en) 1998-11-27 2004-01-15 Celltech R&D, Inc. Compositions and methods for increasing bone mineralization
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
CA2529623A1 (en) 2003-06-16 2005-02-17 Celltech R & D, Inc. Antibodies specific for sclerostin and methods for increasing bone mineralization
US8841092B2 (en) * 2006-08-30 2014-09-23 Wisconsin Alumni Research Foundation Reversible natural product glycosyltransferase-catalyzed reactions, compounds and related methods
KR100979928B1 (ko) * 2008-07-16 2010-09-03 한주학 수직축형 부력풍차
SI3066074T1 (sl) * 2013-11-04 2020-03-31 Pfizer Inc. Intermediati in postopki za sintetizacijo derivatov kaliheamicina
US11993625B2 (en) * 2017-01-24 2024-05-28 Pfizer, Inc. Calicheamicin derivatives and antibody drug conjugates thereof
SG11202108655TA (en) * 2019-02-15 2021-09-29 Univ Southern California Lym-1 and lym-2 antibody compositions and improved car constructs
WO2022085762A1 (ja) * 2020-10-22 2022-04-28 富士フイルム株式会社 皮膚感作性測定試薬、化合物、及び皮膚感作性の測定方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2430943A1 (fr) * 1978-07-13 1980-02-08 Toyo Jozo Kk Nouveaux derives disulfures
EP0040506B1 (de) * 1980-05-21 1986-08-20 Teijin Limited Reaktives Polymer und Verfahren zu seiner Herstellung
US4530835A (en) * 1983-07-08 1985-07-23 Warner-Lambert Company CL-1577 Antibiotic compounds and their production
CA1314245C (en) * 1984-05-23 1993-03-09 Franz Jansen Process for the preparation of conjugates in which a monovalent carboxylic ionophore is associated by means of a covalent bond with a macromolecule, which are useful as immunotoxin potentiators
DE3588213T2 (de) * 1984-11-16 1999-09-30 American Cyanamid Co., Wayne Antitumorale Antibiotika (Komplex LL-E-33288)
EP0330874A3 (de) * 1988-02-29 1989-10-18 American Cyanamid Company Antibakterielle und Antitumor-Mittel LL-E33288 epsilon-I und LL-E33288-epsilon-Br, deren Herstellungen und Zwischenprodukte
EP0342341A3 (de) * 1988-05-17 1991-07-24 American Cyanamid Company Verfahren zur Herstellung von Antitumor-Antibiotika LL-E33288 Gamma 2

Also Published As

Publication number Publication date
DK602588D0 (da) 1988-10-28
NO173506C (no) 1993-12-22
AU2448988A (en) 1989-05-04
ES2061586T3 (es) 1994-12-16
FI95204B (fi) 1995-09-29
FI95204C (fi) 1996-01-10
NZ226726A (en) 1991-08-27
AU618763B2 (en) 1992-01-09
IL87946A0 (en) 1989-03-31
FI91262C (fi) 1994-06-10
EP0313874A2 (de) 1989-05-03
KR890006244A (ko) 1989-06-12
DK602488A (da) 1989-05-01
NO176480B (no) 1995-01-02
IL87947A0 (en) 1989-03-31
IE883261L (en) 1989-04-30
CA1321582C (en) 1993-08-24
IL87947A (en) 1995-05-26
FI884983A0 (fi) 1988-10-28
HK131997A (en) 1997-10-03
PT88881B (pt) 1993-01-29
AU612714B2 (en) 1991-07-18
BR1100939A (pt) 1999-08-31
ATE104309T1 (de) 1994-04-15
IE883262L (en) 1989-04-30
KR970011385B1 (ko) 1997-07-10
NZ226727A (en) 1991-12-23
AR246083A1 (es) 1994-03-30
AU2449488A (en) 1989-05-04
IE65989B1 (en) 1995-11-29
HK131897A (en) 1997-10-03
IE65053B1 (en) 1995-10-04
NO884834L (no) 1989-05-02
JP2720933B2 (ja) 1998-03-04
DE3851682T2 (de) 1995-05-04
JP2820256B2 (ja) 1998-11-05
DE3851682D1 (de) 1994-11-03
FI884984A0 (fi) 1988-10-28
DE3889063T2 (de) 1994-12-01
DK602488D0 (da) 1988-10-28
JPH01193282A (ja) 1989-08-03
DE3889063D1 (de) 1994-05-19
ES2059464T3 (es) 1994-11-16
NO173506B (no) 1993-09-13
IL87946A (en) 1995-06-29
ZA888123B (en) 1989-07-26
EP0313874A3 (en) 1990-05-09
ZA888127B (en) 1989-07-26
EP0313874B1 (de) 1994-04-13
FI884983A (fi) 1989-05-01
KR890006245A (ko) 1989-06-12
FI91262B (fi) 1994-02-28
JPH0296599A (ja) 1990-04-09
DK174739B1 (da) 2003-10-13
EP0313873B1 (de) 1994-09-28
FI884984A (fi) 1989-05-01
DK602588A (da) 1989-05-01
PT88882B (pt) 1993-01-29
NO884833L (no) 1989-05-02
NO884834D0 (no) 1988-10-28
EP0313873A1 (de) 1989-05-03
KR0133130B1 (ko) 1998-04-17
ATE112172T1 (de) 1994-10-15
NO884833D0 (no) 1988-10-28

Similar Documents

Publication Publication Date Title
PT86875A (pt) Process for the preparation of phenylcarbamate
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
YU143688A (en) Process for obtaining 4-phosphatic derivatives of epidofilotoxine glucozide
FI880757A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia tyydytettyjä heterosyklisiä karboksamidijohdoksia
FI95712C (fi) Menetelmä steroidi-5- -reduktaasin inhibiittorien valmistamiseksi
NO180010C (no) Fremgangsmåte for fremstilling av sukrose-6-ester
FI883064A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
NO176758C (no) Analogifremgangsmåte for fremstilling av terapeutiske anvendbare tetrazolyl-bifenylylmetyl-pyrimidiner
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
NO176480C (no) Analogifremgangsmåte ved fremstilling av målrettede former av metyltritio-anti-tumormidler
YU20288A (en) Process for preparing derivatives of adenosyn 5-carboxamides
ES2022079A4 (es) Proceso de fabricacion de alquiloligoglicosidas
PT87191A (pt) Process for the preparation of nucleosides
NO175299C (no) Fremgangsmåte for kontinuerlig raffinering av silisium
YU187788A (en) Process for obtaining new derivatives of dideoxycitidyne
NO174959C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive N-aminobutyl-N-fenyl-arylamidderivater
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI884910A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten bentsopyraanijohdannaisten valmistamiseksi
YU19690A (en) Process for obtaining new derivatives of benzonitryl
FI880716A (fi) Menetelmä terapeuttisesti käyttökelpoisten aryylipiperatsinyylialkyleenifenyylisubstituoitujen heterosyklisten yhdisteiden valmistamiseksi
YU16688A (en) Process for obtaining derivatives of benzoyl-urea
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI885045A (fi) Menetelmä polynukleotidien valmistamiseksi
PT87705A (pt) Process for the preparation of 6-deoxy guanine derivative
NO176565C (no) Analogifremgangsmåte for fremstilling av antitrombotisk aktive forbindelser

Legal Events

Date Code Title Description
MK1K Patent expired